Patents Assigned to NEPHROSANT, INC.
  • Kits for stabilizing analytes in urine samples
    Patent number: 11642107
    Abstract: Disclosed here are kits comprising pre-packed stabilizing solutions for stabilizing combinations of biomarkers at room temperature. Such kits can be better adapted for sample collection at a subject's dwelling, thus easing the burdensome requirement of sample collection.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: May 9, 2023
    Assignee: NEPHROSANT, INC.
    Inventors: Robert Zawada, Corinne Mark, Christopher Goulart
  • Kits for stabilization of cfDNA in urine samples
    Patent number: 11622752
    Abstract: Disclosed here are kits comprising pre-packed stabilizing solutions for stabilizing combinations of biomarkers demonstrating sufficient accuracy and specificity for identifying kidney injuries. Such kits can be better adapted for sample collection at a subject's dwelling, thus easing the burdensome requirement of continuous monitoring for kidney injury.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: April 11, 2023
    Assignee: NEPHROSANT, INC.
    Inventors: Robert Zawada, Corinne Mark, Christopher Goulart
  • Kits for stabilizing analytes in urine samples at room temperature
    Patent number: 11504098
    Abstract: Disclosed here are kits comprising pre-packed stabilizing solutions for stabilizing combinations of biomarkers at room temperature. Such kits can be better adapted for sample collection at a subject's dwelling, thus easing the burdensome requirement of sample collection.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: November 22, 2022
    Assignee: NEPHROSANT, INC.
    Inventors: Robert Zawada, Corinne Mark, Christopher Goulart